SEC Form 4 · accession 0001144204-18-064951
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles S. Ryan
Officer — Chief Executive Officer · Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 17, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.37 | Dec 14, 2018 | A | 79,097 | A | — | Dec 14, 2028 | Common Stock | 79,097 | 79,097 | D |
Explanation of responses
- F1The stock options shall vest in equal daily installments over a three-year period beginning on the date of grant.
Remarks
The stock option grant was made on the one-year anniversary of the effective date of Dr. Ryan's employment agreement pursuant to the terms of such employment agreement.